Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra
about
Inhibition of striatal soluble guanylyl cyclase-cGMP signaling reverses basal ganglia dysfunction and akinesia in experimental parkinsonismModulation of Kv3 potassium channels expressed in CHO cells by a nitric oxide-activated phosphataseReview: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibitionNitric oxide regulates synaptic transmission between spiny projection neuronsAbnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice.Nitric oxide, endothelin and nephron transport: potential interactions.Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades.Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurinNetwork compensation of cyclic GMP-dependent protein kinase II knockout in the hippocampus by Ca2+-permeable AMPA receptors.Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp).Nitric oxide, cGMP, and hormone regulation of active sodium transport.Pass the nitric oxide.NO donors inhibit Na,K-ATPase activity by a protein kinase G-dependent mechanism in the nonpigmented ciliary epithelium of the porcine eye.The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.Long-term depression: a learning-related type of synaptic plasticity in the mammalian central nervous system.The intercalated nuclear complex of the primate amygdalaStriatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo.Retrospection on the Role of Soluble Guanylate Cyclase in Parkinson's Disease.Nitric oxide stimulates tyrosine phosphorylation in murine fibroblasts in the absence and presence of epidermal growth factor.Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons.Dopaminergic D2 receptors activate PKA to inhibit spinal pelvic-urethra reflex in rats.Aromatic L-amino acid decarboxylase phosphorylation and activation by PKGIalpha in vitro.Carbachol inhibits Na(+)-K(+)-ATPase activity in choroid plexus via stimulation of the NO/cGMP pathway.Nitric oxide regulates adenylyl cyclase activity in rat striatal membranes.Oestradiol increases phosphorylation of a dopamine- and cyclic AMP-regulated phosphoprotein (DARPP-32) in female rat brain.Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore.Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease.C-type natriuretic peptide (CNP) regulates cocaine-induced dopamine increase and immediate early gene expression in rat brain.Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism.Regulation of Striatal Neuron Activity by Cyclic Nucleotide Signaling and Phosphodiesterase Inhibition: Implications for the Treatment of Parkinson's Disease.Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic nucleotide-dependent kinases in vitro and in rat cerebellar slices in situ.Inhibition of Na,K-ATPase activity by cGMP is isoform-specific in brain endothelial cells.Modulation of the voltage-gated sodium current in rat striatal neurons by DARPP-32, an inhibitor of protein phosphatase.
P2860
Q21090973-5035B2A6-CF85-4D00-BC87-93677AC6468EQ28361669-06A19B32-41C1-4592-A6FE-818448A33193Q28394979-CFB23A80-BE6B-42FB-A2C2-C25337081FA9Q29144892-497B8DD2-4130-44AC-9871-974D333DF09AQ30488182-19FFB4E5-F2A8-4C02-BFAD-0479B5B25CFBQ33542408-6EDEA186-5F60-4C55-8321-F528324FE0EAQ33762162-4BF621CC-962A-4677-9B3D-459AE9C5792BQ34492149-E83EE810-5A8F-4681-B173-9F2FB909F32EQ35189809-B5AF2744-0837-492B-87A2-6D320A3B0D16Q35776107-C7681E73-0A01-45E4-8357-0D93D64EB505Q35956885-6B8FD222-2B9C-40FF-8ED7-37862E73BD1FQ36292594-425D7684-8C8B-4B34-B3A6-2BE6CE55D032Q38758245-79808BF8-0115-4E1A-AFA6-99C94B45E8CBQ40345085-0C3F3F97-ECF0-4F20-9D75-4F90459A6D85Q41040000-457928F7-1D83-4694-8454-32F5D65DB11EQ42274709-E218F167-CAE5-4725-99D4-A9AD53034048Q42486333-5F1053DF-EB36-4D0D-91C6-C0B523B04879Q42699608-255BB2BD-D769-4B8C-B8EE-66FED8A36D16Q42823499-1CA61DB2-AD9A-4F4D-8E84-0833DB4A1776Q42989363-5C9C77E9-9A5D-4E63-81E4-1E281D79D578Q43017137-63F282D3-04C3-4D78-8E0A-7DF7CB0BFF04Q43067878-3D9A2690-CC41-4965-A1A1-E06CEAF2FE5FQ43509897-13D0E934-0EEB-4619-B6EB-BB96E1E3821BQ43627929-98182623-E5CE-4EC9-906C-DB69A028685BQ43751783-768D4EF4-CC67-466B-B583-A4E3A0CB4A52Q43777343-BC4950BE-651B-4F23-8612-ABD40398141FQ43830037-2BFBEF90-C42D-43E7-85AF-571A2353419AQ43892574-D53DFD89-8BE3-4708-8BD0-771FA622D415Q46597028-DA987F0F-8DEE-48D4-996F-753CDC75065DQ47909580-CBA954E5-508F-4247-87FA-2D870FAB467FQ48270143-C29F51C9-9DAC-4F27-B45C-563A85256436Q48360377-9D650965-B2C3-4FF9-A51D-FDEC3327E359Q48388865-2EDDECFE-BA1D-46CD-8693-5C58B25EEBD6
P2860
Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Nitric oxide/cGMP pathway stim ...... otein, in the substantia nigra
@ast
Nitric oxide/cGMP pathway stim ...... otein, in the substantia nigra
@en
type
label
Nitric oxide/cGMP pathway stim ...... otein, in the substantia nigra
@ast
Nitric oxide/cGMP pathway stim ...... otein, in the substantia nigra
@en
prefLabel
Nitric oxide/cGMP pathway stim ...... otein, in the substantia nigra
@ast
Nitric oxide/cGMP pathway stim ...... otein, in the substantia nigra
@en
P2860
P356
P1476
Nitric oxide/cGMP pathway stim ...... otein, in the substantia nigra
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.8.3462
P407
P577
1993-04-01T00:00:00Z